These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26238658)

  • 1. Inhibiting GLUT-1 expression and PI3K/Akt signaling using apigenin improves the radiosensitivity of laryngeal carcinoma in vivo.
    Bao YY; Zhou SH; Lu ZJ; Fan J; Huang YP
    Oncol Rep; 2015 Oct; 34(4):1805-14. PubMed ID: 26238658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-Inhibition of GLUT-1 Expression and the PI3K/Akt Signaling Pathway to Enhance the Radiosensitivity of Laryngeal Carcinoma Xenografts In Vivo.
    Luo XM; Xu B; Zhou ML; Bao YY; Zhou SH; Fan J; Lu ZJ
    PLoS One; 2015; 10(11):e0143306. PubMed ID: 26600164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo evaluation of the effects of simultaneous inhibition of GLUT-1 and HIF-1α by antisense oligodeoxynucleotides on the radiosensitivity of laryngeal carcinoma using micro 18F-FDG PET/CT.
    Shen LF; Zhao X; Zhou SH; Lu ZJ; Zhao K; Fan J; Zhou ML
    Oncotarget; 2017 May; 8(21):34709-34726. PubMed ID: 28410229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Glut-1 and HIF-1α double knockout by CRISPR/CAS9 on radiosensitivity in laryngeal carcinoma via the PI3K/Akt/mTOR pathway.
    Bao YY; Zhong JT; Shen LF; Dai LB; Zhou SH; Fan J; Yao HT; Lu ZJ
    J Cell Mol Med; 2022 May; 26(10):2881-2894. PubMed ID: 35415942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antisense oligodeoxynucleotides glucose transporter-1 on enhancement of radiosensitivity of laryngeal carcinoma.
    Yan SX; Luo XM; Zhou SH; Bao YY; Fan J; Lu ZJ; Liao XB; Huang YP; Wu TT; Wang QY
    Int J Med Sci; 2013; 10(10):1375-86. PubMed ID: 23983599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apigenin inhibits the GLUT-1 glucose transporter and the phosphoinositide 3-kinase/Akt pathway in human pancreatic cancer cells.
    Melstrom LG; Salabat MR; Ding XZ; Milam BM; Strouch M; Pelling JC; Bentrem DJ
    Pancreas; 2008 Nov; 37(4):426-31. PubMed ID: 18953257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apigenin suppresses GLUT-1 and p-AKT expression to enhance the chemosensitivity to cisplatin of laryngeal carcinoma Hep-2 cells: an in vitro study.
    Xu YY; Wu TT; Zhou SH; Bao YY; Wang QY; Fan J; Huang YP
    Int J Clin Exp Pathol; 2014; 7(7):3938-47. PubMed ID: 25120770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of combination of curcumin and GLUT-1 AS-ODN on radiosensitivity of laryngeal carcinoma through regulating autophagy.
    Dai LB; Yu Q; Zhou SH; Bao YY; Zhong JT; Shen LF; Lu ZJ; Fan J; Huang YP
    Head Neck; 2020 Sep; 42(9):2287-2297. PubMed ID: 32314842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer mechanism of apigenin and the implications of GLUT-1 expression in head and neck cancers.
    Bao YY; Zhou SH; Fan J; Wang QY
    Future Oncol; 2013 Sep; 9(9):1353-64. PubMed ID: 23980682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apigenin sensitizes doxorubicin-resistant hepatocellular carcinoma BEL-7402/ADM cells to doxorubicin via inhibiting PI3K/Akt/Nrf2 pathway.
    Gao AM; Ke ZP; Wang JN; Yang JY; Chen SY; Chen H
    Carcinogenesis; 2013 Aug; 34(8):1806-14. PubMed ID: 23563091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galangin suppresses human laryngeal carcinoma via modulation of caspase-3 and AKT signaling pathways.
    Wang HX; Tang C
    Oncol Rep; 2017 Aug; 38(2):703-714. PubMed ID: 28677816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells.
    Xiong F; Jiang M; Huang Z; Chen M; Chen K; Zhou J; Yin L; Tang Y; Wang M; Ye L; Zhan Z; Duan J; Fu H; Zhang X
    Integr Cancer Ther; 2014 Mar; 13(2):152-60. PubMed ID: 24105357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect on the expression of MMP-2, MT-MMP in laryngeal carcinoma Hep-2 cell line by antisense glucose transporter-1.
    Xu YY; Bao YY; Zhou SH; Fan J
    Arch Med Res; 2012 Jul; 43(5):395-401. PubMed ID: 22835601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting XIAP expression by RNAi to inhibit proliferation and enhance radiosensitivity in laryngeal cancer cell line.
    Wang R; Li B; Wang X; Lin F; Gao P; Cheng SY; Zhang HZ
    Auris Nasus Larynx; 2009 Jun; 36(3):332-9. PubMed ID: 19013033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GLUT-1 participates in the promotion of LncRNA CASC9 in proliferation and metastasis of laryngeal carcinoma cells.
    Xi J; Wang Y; Liu H
    Gene; 2020 Feb; 726():144194. PubMed ID: 31669650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of glutamine utilization sensitizes lung cancer cells to apigenin-induced apoptosis resulting from metabolic and oxidative stress.
    Lee YM; Lee G; Oh TI; Kim BM; Shim DW; Lee KH; Kim YJ; Lim BO; Lim JH
    Int J Oncol; 2016 Jan; 48(1):399-408. PubMed ID: 26573871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of Survivin by shRNA Inhibits Invasion and Enhances the Radiosensitivity of Laryngeal Squamous Cell Carcinoma.
    Hu J; Pan J; Luo Z; Tao Z
    Cell Biochem Biophys; 2015 May; 72(1):251-7. PubMed ID: 25701406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Descending-SHIP2-mediated radiosensitivity enhancement through PI3K/Akt signaling pathway in laryngeal squamous cell carcinoma.
    Tang T; Xiao ZY; Shan G; Lei HB
    Biomed Pharmacother; 2019 Oct; 118():109392. PubMed ID: 31545285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mango polyphenolics suppressed tumor growth in breast cancer xenografts in mice: role of the PI3K/AKT pathway and associated microRNAs.
    Banerjee N; Kim H; Krenek K; Talcott ST; Mertens-Talcott SU
    Nutr Res; 2015 Aug; 35(8):744-51. PubMed ID: 26194618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apigenin inhibits the proliferation of adenoid cystic carcinoma via suppression of glucose transporter-1.
    Fang J; Bao YY; Zhou SH; Fan J
    Mol Med Rep; 2015 Nov; 12(5):6461-6. PubMed ID: 26300442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.